Ilya Zubkov
Stock Analyst at Freedom Broker
(2.15)
# 3,189
Out of 5,182 analysts
77
Total ratings
45.9%
Success rate
-5.65%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Initiates: Buy | $12 | $7.05 | +70.21% | 1 | Apr 7, 2026 | |
| ANGO AngioDynamics | Initiates: Buy | $16 | $10.97 | +45.85% | 1 | Apr 6, 2026 | |
| IRMD IRADIMED CORPORATION | Initiates: Buy | $116 | $85.86 | +35.10% | 1 | Apr 2, 2026 | |
| LFMD LifeMD | Maintains: Buy | $8 → $10 | $5.13 | +94.93% | 4 | Mar 12, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $100 → $105 | $53.24 | +97.22% | 2 | Mar 2, 2026 | |
| BFLY Butterfly Network | Maintains: Buy | $5 → $5.5 | $4.82 | +14.11% | 2 | Mar 2, 2026 | |
| LGCY Legacy Education | Maintains: Buy | $13 → $15 | $11.20 | +29.46% | 4 | Feb 24, 2026 | |
| BIIB Biogen | Maintains: Hold | $160 → $185 | $189.13 | -2.18% | 3 | Feb 23, 2026 | |
| LFVN LifeVantage | Maintains: Buy | $17 → $11 | $5.49 | +100.36% | 4 | Feb 18, 2026 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $470 → $410 | $301.11 | +36.16% | 2 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $245 → $260 | $206.11 | +26.15% | 3 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $36 | $25.81 | +39.48% | 4 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $360 → $375 | $329.59 | +13.78% | 2 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1,050 → $1,200 | $988.87 | +21.35% | 4 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $110 | $113.15 | -2.78% | 3 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $33 | $26.45 | +24.76% | 2 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $130 → $120 | $87.17 | +37.66% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $190 → $220 | $225.55 | -2.46% | 4 | Jan 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $610 | $451.38 | +35.14% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $16 → $4 | $4.76 | -15.97% | 4 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $11.45 | -21.40% | 1 | Dec 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.93 | +55.44% | 1 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1 | $2.33 | -57.08% | 2 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $7.67 | +82.53% | 2 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $15 | $4.96 | +202.42% | 2 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $4.5 | $1.03 | +336.89% | 3 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $38 | $40.97 | -7.25% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $2.87 | +109.06% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $9.5 → $1 | $0.84 | +18.74% | 1 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.00 | +200.00% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $3.93 | +103.56% | 2 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $4 | $1.54 | +159.74% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $14 → $37 | $21.79 | +69.80% | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $15 → $1.5 | $5.21 | -71.19% | 1 | May 16, 2025 |
Inogen
Apr 7, 2026
Initiates: Buy
Price Target: $12
Current: $7.05
Upside: +70.21%
AngioDynamics
Apr 6, 2026
Initiates: Buy
Price Target: $16
Current: $10.97
Upside: +45.85%
IRADIMED CORPORATION
Apr 2, 2026
Initiates: Buy
Price Target: $116
Current: $85.86
Upside: +35.10%
LifeMD
Mar 12, 2026
Maintains: Buy
Price Target: $8 → $10
Current: $5.13
Upside: +94.93%
BioMarin Pharmaceutical
Mar 2, 2026
Maintains: Buy
Price Target: $100 → $105
Current: $53.24
Upside: +97.22%
Butterfly Network
Mar 2, 2026
Maintains: Buy
Price Target: $5 → $5.5
Current: $4.82
Upside: +14.11%
Legacy Education
Feb 24, 2026
Maintains: Buy
Price Target: $13 → $15
Current: $11.20
Upside: +29.46%
Biogen
Feb 23, 2026
Maintains: Hold
Price Target: $160 → $185
Current: $189.13
Upside: -2.18%
LifeVantage
Feb 18, 2026
Maintains: Buy
Price Target: $17 → $11
Current: $5.49
Upside: +100.36%
Alnylam Pharmaceuticals
Feb 17, 2026
Upgrades: Buy
Price Target: $470 → $410
Current: $301.11
Upside: +36.16%
Feb 17, 2026
Maintains: Buy
Price Target: $245 → $260
Current: $206.11
Upside: +26.15%
Feb 12, 2026
Maintains: Buy
Price Target: $34 → $36
Current: $25.81
Upside: +39.48%
Feb 12, 2026
Downgrades: Hold
Price Target: $360 → $375
Current: $329.59
Upside: +13.78%
Feb 10, 2026
Upgrades: Buy
Price Target: $1,050 → $1,200
Current: $988.87
Upside: +21.35%
Feb 9, 2026
Maintains: Hold
Price Target: $90 → $110
Current: $113.15
Upside: -2.78%
Feb 9, 2026
Maintains: Buy
Price Target: $35 → $33
Current: $26.45
Upside: +24.76%
Jan 29, 2026
Upgrades: Buy
Price Target: $130 → $120
Current: $87.17
Upside: +37.66%
Jan 27, 2026
Maintains: Hold
Price Target: $190 → $220
Current: $225.55
Upside: -2.46%
Jan 26, 2026
Upgrades: Buy
Price Target: $560 → $610
Current: $451.38
Upside: +35.14%
Jan 21, 2026
Downgrades: Sell
Price Target: $16 → $4
Current: $4.76
Upside: -15.97%
Dec 30, 2025
Initiates: Buy
Price Target: $9
Current: $11.45
Upside: -21.40%
Dec 17, 2025
Initiates: Buy
Price Target: $3
Current: $1.93
Upside: +55.44%
Nov 21, 2025
Maintains: Buy
Price Target: $2 → $1
Current: $2.33
Upside: -57.08%
Nov 21, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $7.67
Upside: +82.53%
Nov 20, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $4.96
Upside: +202.42%
Nov 20, 2025
Maintains: Buy
Price Target: $22 → $4.5
Current: $1.03
Upside: +336.89%
Oct 17, 2025
Initiates: Buy
Price Target: $38
Current: $40.97
Upside: -7.25%
Oct 1, 2025
Initiates: Buy
Price Target: $6
Current: $2.87
Upside: +109.06%
Sep 19, 2025
Downgrades: Hold
Price Target: $9.5 → $1
Current: $0.84
Upside: +18.74%
Sep 17, 2025
Initiates: Buy
Price Target: $9
Current: $3.00
Upside: +200.00%
Aug 15, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.93
Upside: +103.56%
Aug 12, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $1.54
Upside: +159.74%
Aug 11, 2025
Upgrades: Buy
Price Target: $14 → $37
Current: $21.79
Upside: +69.80%
May 16, 2025
Downgrades: Hold
Price Target: $15 → $1.5
Current: $5.21
Upside: -71.19%